-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Chemed to Sector Perform, Lowers Price Target to $422

Benzinga·02/27/2026 18:36:12
Listen to the news
RBC Capital analyst Ben Hendrix downgrades Chemed (NYSE:CHE) from Outperform to Sector Perform and lowers the price target from $572 to $422.